- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07716436
Intradialytic Versus Home-Based Exercise in Female Hemodialysis Patients
Comparing the Effect of Intradialytic and Home-Based Exercise on Health Outcomes, Quality of Life, Self-Esteem, and Sexual Function in Female Hemodialysis Patients
This randomized controlled trial compared intradialytic exercise with home-based exercise in married female patients receiving maintenance hemodialysis. Ninety participants were randomly assigned in equal numbers to an intradialytic exercise group, a home-based exercise group, or a control group. Both exercise programs continued for 12 weeks.
The study evaluated whether exercise performed during dialysis or at home could improve quality of life, self-esteem, sexual function, and selected clinical and laboratory outcomes. Quality of life was assessed using the 36-Item Short Form Survey, self-esteem using the Rosenberg Self-Esteem Scale, and sexual function using the Female Sexual Function Index. Laboratory assessments included calcium, phosphorus, intact parathyroid hormone, albumin, C-reactive protein, hemoglobin, sodium, and potassium.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Gharbia Governorate
-
Tanta, Gharbia Governorate, Egypte, 31511
- Tanta University Hospitals
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Female patients older than 18 years.
- Clinically stable.
- Receiving regular maintenance hemodialysis three times per week for at least three months.
- Able to perform mild- to moderate-intensity exercise.
Exclusion Criteria:
- Physical limitations preventing exercise.
- Acute illness.
- Unstable cardiovascular disease.
- Severe orthopedic or neurological disorders.
- Cognitive impairment affecting cooperation.
- Dialysis instability.
- Severe chronic kidney disease-mineral and bone disorder.
- Significant anemia.
- Retinal hemorrhage.
- History of hyperthyroidism.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Intradialytic Exercise
Participants performed low- to moderate-intensity aerobic and resistance exercises during the first two hours of hemodialysis, three times per week for 12 weeks.
Each session included a 5-minute warm-up, followed by aerobic and resistance exercises.
The conditioning phase started at 10 minutes and gradually increased to 30 minutes according to tolerance, followed by 5 minutes of relaxation and breathing exercises.
Exercise intensity was maintained at 60%-70% of maximal heart rate and monitored using the Borg scale.
Sessions were supervised by a trained dialysis nurse.
|
A supervised low- to moderate-intensity aerobic and resistance exercise program performed during the first two hours of hemodialysis, three times per week for 12 weeks.
|
|
Experimenteel: Home-Based Exercise
Participants performed a structured home-based exercise program for 30 minutes per day, at least three to five times per week, for 12 weeks.
The program included walking, bodyweight resistance exercises, and flexibility routines.
Participants received instructions on safe exercise performance and were advised to adjust the exercise intensity according to tolerance.
|
A structured home-based exercise program consisting of walking, bodyweight resistance exercises, and flexibility routines for 30 minutes per day, at least three to five times per week for 12 weeks.
|
|
Geen tussenkomst: Control
Participants continued their usual hemodialysis care without a structured exercise program during the 12-week study period.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Health-Related Quality of Life
Tijdsspanne: Baseline and 12 weeks
|
Change in Health-Related Quality of Life was assessed by the 36-Item Short Form Survey.
The 36-Item Short Form Survey consists of 36 items covering eight health domains: physical functioning, role limitations due to physical health, bodily pain, general health perceptions, energy/fatigue, social functioning, role limitations due to emotional problems, and emotional well-being.
Each domain is scored from 0 to 100, with 0 representing the lowest possible health status and 100 representing the highest possible health status.
Higher scores indicate better health-related quality of life.
The validated Arabic version was used.
|
Baseline and 12 weeks
|
|
Self-Esteem
Tijdsspanne: Baseline and 12 weeks
|
Change in Self-Esteem was assessed by the Rosenberg Self-Esteem Scale.
The Rosenberg Self-Esteem Scale consists of 10 items assessing global self-esteem, including five positively worded and five negatively worded statements.
Higher total scores indicate higher self-esteem.
|
Baseline and 12 weeks
|
|
Female sexual function
Tijdsspanne: Baseline and 12 weeks
|
Change in Female Sexual Function was assessed by the Female Sexual Function Index.
The Female Sexual Function Index consists of 19 items covering six domains of female sexual function: desire, arousal, lubrication, orgasm, satisfaction, and pain.
The total score ranges from 2 to 36, with higher scores indicating better sexual function.
The validated Arabic version was used.
|
Baseline and 12 weeks
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Urogenitale ziekten
- Pathologische processen
- Mannelijke urogenitale ziekten
- Nier Ziekten
- Urologische ziekten
- Vrouwelijke urogenitale ziekten
- Vrouwelijke urogenitale ziekten en zwangerschapscomplicaties
- Chronische ziekte
- Ziekte attributen
- Nierinsufficiëntie
- Nierinsufficiëntie, chronisch
- Pathologische aandoeningen, tekenen en symptomen
- Gedrag
- Nierfalen, chronisch
- Motorische activiteit
Andere studie-ID-nummers
- 36264PR1100/2/25
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
IPD-tijdsbestek voor delen
IPD-toegangscriteria voor delen
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
- SAP
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .